1-12 of 12
John M. Harlan
Close
Sort by
Journal Articles

Treatment Recommendations for Patients with NHL at the Uganda Cancer Institute

Manoj P Menon, MD, MPH, Anna Coghill, PhD, Innocent Mutyaba, MD, Fred Okuku, MD, Warren Phipps, MD, MPH, John M. Harlan, MD, Jackson Orem, MD, Corey Casper
Journal: Blood
Blood (2013) 122 (21): 2960.
https://doi.org/10.1182/blood.V122.21.2960.2960
Published: 2013
Journal Articles

Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia

Pamela S. Becker, Kenneth J. Kopecky, Adrianne N. Wilks, Sylvia Chien, John M. Harlan, Cheryl L. Willman, Stephen H. Petersdorf, Derek L. Stirewalt, Thalia Papayannopoulou, Frederick R. Appelbaum
Journal: Blood
Blood (2009) 113 (4): 866–874.
https://doi.org/10.1182/blood-2007-12-124818
Published: 2009
Includes: Supplemental data
Journal Articles

Very Late Antigen-4 (VLA-4) Expression by AML Blasts: Correlation of VCAM-1 Binding to Overall Survival.

Pamela S. Becker, MD, PhD, Thalia Papayannopoulou, MD, DSci, Kenneth J. Kopecky, PhD, Adrianne N. Hanks, BA, John M. Harlan, MD, Cheryl L. Willman, MD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2005) 106 (11): 2365.
https://doi.org/10.1182/blood.V106.11.2365.2365
Published: 2005
Journal Articles

Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-α–stimulated neutrophils

Chien-Ying Liu, Akihiro Takemasa, W. Conrad Liles, Richard B. Goodman, Mechthild Jonas, Henry Rosen, Emil Chi, Robert K. Winn, John M. Harlan, Peter I. Chuang
Journal: Blood
Blood (2003) 101 (1): 295–304.
https://doi.org/10.1182/blood-2001-12-0266
Published: 2003
Journal Articles

The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials

Akiko Iwata, John M. Harlan, Nicholas B. Vedder, Robert K. Winn
Journal: Blood
Blood (2002) 100 (6): 2077–2080.
https://doi.org/10.1182/blood-2002-03-0752
Published: 2002
Journal Articles

Perturbation of B-cell development in mice overexpressing the Bcl-2 homolog A1

Peter I. Chuang, Samantha Morefield, Chien-Ying Liu, Stephen Chen, John M. Harlan, Dennis M. Willerford
Journal: Blood
Blood (2002) 99 (9): 3350–3359.
https://doi.org/10.1182/blood.V99.9.3350
Published: 2002
Journal Articles

Synergistic mobilization of hemopoietic progenitor cells using concurrent β1 and β2 integrin blockade or β2-deficient mice

Thalia Papayannopoulou, Gregory V. Priestley, Betty Nakamoto, Vivian Zafiropoulos, Linda M. Scott, John M. Harlan
Journal: Blood
Blood (2001) 97 (5): 1282–1288.
https://doi.org/10.1182/blood.V97.5.1282
Published: 2001
Journal Articles

Introduction: anti-adhesion therapy in sickle cell disease

John M. Harlan
Journal: Blood
Blood (2000) 95 (2): 365–367.
https://doi.org/10.1182/blood.V95.2.365
Published: 2000
Journal Articles

Of Man and Mouse: Leukocyte and Endothelial Adhesion Molecule Deficiencies

Amos Etzioni, Claire M. Doerschuk, John M. Harlan
Journal: Blood
Blood (1999) 94 (10): 3281–3288.
https://doi.org/10.1182/blood.V94.10.3281.422k37_3281_3288
Published: 1999
Journal Articles

Endothelial Cells Undergoing Apoptosis Become Proadhesive for Nonactivated Platelets

Thomas Bombeli, Barbara R. Schwartz, John M. Harlan
Journal: Blood
Blood (1999) 93 (11): 3831–3838.
https://doi.org/10.1182/blood.V93.11.3831
Published: 1999
Journal Articles

Lipopolysaccharide Induces the Antiapoptotic Molecules, A1 and A20, in Microvascular Endothelial Cells

Xiaolong Hu, Esther Yee, John M. Harlan, Fred Wong, Aly Karsan
Journal: Blood
Blood (1998) 92 (8): 2759–2765.
https://doi.org/10.1182/blood.V92.8.2759
Published: 1998
Journal Articles

Apoptotic Vascular Endothelial Cells Become Procoagulant

Thomas Bombeli, Aly Karsan, Jonathan F. Tait, John M. Harlan
Journal: Blood
Blood (1997) 89 (7): 2429–2442.
https://doi.org/10.1182/blood.V89.7.2429
Published: 1997